» Articles » PMID: 971460

Ten Cases of Malignant Hyperthermia in Norway

Overview
Specialty Anesthesiology
Date 1976 Sep 1
PMID 971460
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Data are presented on ten cases of anaesthesia-induced malignant hyperthermia in Norway. Seven of the patients died, three recovered. The fatal cases were all boys in the age group 11-20 years. This age and sex distribution suggests that puberty with the increase in androgens is a precipitating factor in malignant hyperthermia. One of the victims who survived was a 4 1/2-year-old pseudohermaphrodite girl with the adrenogenital syndrome. The coincidence of malignant hyperthermia in a patient with such a rare syndrome points to the excessive formation of androgens in patients with this syndrome as a predisposing factor. The indications for surgery were traumatic injuries in five cases, congenital abnormalities in three and appendicitis in two cases. These conditions in themselves may cause an increased sensitivity to suxamethonium. One patient received only hexobarbitone, halothane and suxamethonium. After the last drug jaw rigidity and temperature rise to 41.3 degrees C prompted the anaesthetist to end the anaesthetic. The fact that the patient survived proves that suxamethonium induced jaw rigidity is valuable as a warning. The absence of cardiovascular depression after procaine 3.5 g in one patient is ascribed to the correction of acidosis at the time of infusion of this drug. It is suggested that procaine should be withheld until other measures such as cooling, correction of acidosis and steroid therapy have been tried.

Citing Articles

An Assessment of Penetrance and Clinical Expression of Malignant Hyperthermia in Individuals Carrying Diagnostic Ryanodine Receptor 1 Gene Mutations.

Ibarra Moreno C, Hu S, Kraeva N, Schuster F, Johannsen S, Rueffert H Anesthesiology. 2019; 131(5):983-991.

PMID: 31206373 PMC: 9912949. DOI: 10.1097/ALN.0000000000002813.


Suxamethonium-induced jaw stiffness and myalgia associated with atypical cholinesterase: case report.

Melvoll R, Stovner J, Whittaker M Can Anaesth Soc J. 1980; 27(3):283-5.

PMID: 7378868 DOI: 10.1007/BF03007441.


Masseter contracture and tachycardia causing termination of anesthesia.

Burger B, Malsch E, Mayer B Anesth Prog. 1984; 31(6):257-62.

PMID: 6597693 PMC: 2515163.

References
1.
Britt B, Locher W, KALOW W . Hereditary aspects of malignant hyperthermia. Can Anaesth Soc J. 1969; 16(2):89-98. DOI: 10.1007/BF03005788. View

2.
Clarke I, Ellis F . An evaluation of procaine in the treatment of malignant hyperpyrexia. Br J Anaesth. 1975; 47(1):17-21. DOI: 10.1093/bja/47.1.17. View

3.
Britt B . Editorial: Malignant hyperthermia: a pharmacogenetic disease of skeletal and cardiac muscle. N Engl J Med. 1974; 290(20):1140-2. DOI: 10.1056/NEJM197405162902012. View

4.
WEINTRAUB H, Heisterkamp D, COOPERMAN L . Changes in plasma potassium concentration after depolarizing blockers in anaesthetized man. Br J Anaesth. 1969; 41(12):1048-52. DOI: 10.1093/bja/41.12.1048. View

5.
Owen G, KERRY R . Anaesthesia during raised creatine phosphokinase activity. Br Med J. 1974; 4(5936):75-6. PMC: 1612135. DOI: 10.1136/bmj.4.5936.75. View